alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.1



CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND ACTING CHIEF

FINANCIAL OFFICER PURSUANT TO RULE 13A-14 OR 15D-14 OF THE

SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Lindsay Semple, certify that:



1.

I have reviewed this I have reviewed this annual report on Form 10KSB/Amendment No. 1 for the fiscal year ended December 31, 2004, of Global Precision Medical Inc.;



2.

Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3.

Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report.



4.

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and have:



a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



b)

evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and



c)

disclosed in this report any change in the small business issuer's internal control over      financial reporting that occurred during the registrant's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and



5.

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the Registrants auditors and the audit committee of the Registrants board of directors (or persons performing the equivalent functions):



a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's  ability to record, process, summarize and report financial information; and



b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's  internal control over financial reporting.



Date: September 23, 2005



/s/ Lindsay Semple

Lindsay Semple

Chief Executive Officer and Acting Chief Financial Officer
NIOSH
ALERT

Preventing Asthma and Death from Diisocyanate Exposure

WARNING!
Workers exposed to diisocyanates may develop serious or fatal respiratory disease.

Employers should take the following steps
to protect workers from diisocyanate
exposure:

¢ Make workers aware of the serious health
effects that may result from diisocyanate
exposures.

¢ Make workers aware of any materials that
may contain or be contaminated with diiso-
cyanates.

« When feasible, substitute a less hazardous
material for diisocyanates.

¢ Ifsubstitution is not possible, use engineer-
ing controls such as closed systems and
ventilation to minimize exposures.

¢ Provide appropriate respiratory protection
to workers exposed to diisocyanates.

Workers should take the following steps
to protect themselves from diisocy-
anate exposure:

¢ Be aware that the highest diisocyanate
concentrations may occur inside contain-
ment structures.

Use appropriate respiratory protection
when working with diisocyanates.

Wash hands and face before eating, drink-
ing, or smoking outside the work area.

Shower and change into clean clothes
before leaving the worksite.

Participate in medical monitoring and ex-
amination programs, air monitoring pro-
grams, or training programs offered by
your employer.

For additional information, see NIOSH ALERT: Request
for Assistance in Preventing Asthma and Death from
Diisocyanate Exposure [DHHS (NIOSH) Publication No.
96-111]. Single copies of the Alert are available free from
the following:

Publications Dissemination, EID
National Institute for Occupational Safety and Health
4676 Columbia Parkway
Cincinnati, OH 45226

Fax number: (513) 533-8573
Phone number: 1-800-35-NIOSH (1-800-356-4674)
E-mail: pubstaft @ niosdt1.em.cde.gov

U.S. Department of Health and Human Services
Public Health Service

Centers for Disease Control and Prevention

NIEISH! ational Institute for Occupational Safety and Health

Please tear out and post. Distribute copies to workers.
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
KNICKERBOCKER VILLAGE INC, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                          96,714
<SECURITIES>                                         0
<RECEIVABLES>                                  484,879
<ALLOWANCES>                                   303,000
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,515,327
<PP&E>                                       7,366,158
<DEPRECIATION>                                 384,699
<TOTAL-ASSETS>                              10,135,525
<CURRENT-LIABILITIES>                        1,708,130
<BONDS>                                      6,176,319
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       317,048
<OTHER-SE>                                   1,094,475
<TOTAL-LIABILITY-AND-EQUITY>                10,135,525
<SALES>                                      7,472,684
<TOTAL-REVENUES>                             7,476,806
<CGS>                                                0
<TOTAL-COSTS>                                7,296,495
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             422,058
<INCOME-PRETAX>                                180,311
<INCOME-TAX>                                    29,000
<INCOME-CONTINUING>                            151,311
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   151,311
<EPS-PRIMARY>                                     1.03
<EPS-DILUTED>                                        0
        

</TABLE>
II 

116TH CONGRESS 

1ST SESSION S. 2027 

To amend title 38, United States Code, to expand the scope of the Advisory 

Committee on Minority Veterans, and for other purposes. 

IN THE SENATE OF THE UNITED STATES 

JUNE 27, 2019 

Ms. DUCKWORTH (for herself, Mr. WYDEN, Ms. BALDWIN, Mr. MARKEY, Mrs. 

GILLIBRAND, Mr. DURBIN, Mr. KAINE, Mr. SANDERS, Mrs. SHAHEEN, 

Ms. HIRONO, Ms. HARRIS, Mr. BLUMENTHAL, and Ms. KLOBUCHAR) introduced the following bill; which was read twice and referred to the Committee on Veterans’ Affairs 

A BILL 

To amend title 38, United States Code, to expand the scope 

of the Advisory Committee on Minority Veterans, and 

for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. EXPANSION OF SCOPE OF ADVISORY COM4 MITTEE ON MINORITY VETERANS. 

5 Section 544(d) of title 38, United States Code, is 

6 amended— 

7 (1) in paragraph (4), by striking ‘‘; or’’ and in8 serting a semicolon; 


kjohnson on DSK79L0C42 with BILLS
2 

•S 2027 IS

1 (2) in paragraph (5), by striking the period at 

2 the end and inserting ‘‘; or’’; and 

3 (3) by adding at the end the following new 

4 paragraph: 

5 ‘‘(4) lesbian, gay, bisexual, or transgender.’’. 

Æ 


kjohnson on DSK79L0C42 with BILLS
<TABLE>
                                                                                                 EXHIBIT 12

                     KENTUCKY POWER COMPANY
        Computation of Ratio of Earnings to Fixed Charges
                (in thousands except ratio data)
<CAPTION>
                                                                                                    Twelve
                                                                                                    Months
                                                              Year Ended December 31,               Ended
                                                  1993       1994       1995       1996      1997   3/31/98 
<S>                                             <C>        <C>        <C>       <C>       <C>       <C>
Fixed Charges:                                                                                    
  Interest on First Mortgage Bonds . . . . . .  $17,472    $19,090    $19,090   $14,914   $14,867   $15,696
  Interest on Other Long-term Debt . . . . . .    2,033       -         2,422     6,446     8,597     8,597
  Interest on Short-term Debt. . . . . . . . .    1,001      1,621      2,242     2,849     3,034     2,845
  Miscellaneous Interest Charges . . . . . . .      523        485        510       555       559       592
  Estimated Interest Element in Lease Rentals.      800        700        700       800     1,700     1,700
       Total Fixed Charges . . . . . . . . . .  $21,829    $21,896    $24,964   $25,564   $28,757   $29,430
                                                                                                  
Earnings:                                                                                         
  Net Income . . . . . . . . . . . . . . . . .  $18,031    $25,273    $25,128   $16,973   $20,746   $16,632
  Plus Federal Income Taxes. . . . . . . . . .    1,620      2,178      3,914     5,119     9,415     7,100 
  Plus State Income Taxes. . . . . . . . . . .    1,116      1,154      1,420       598     2,190     1,808
  Plus Fixed Charges (as above). . . . . . . .   21,829     21,896     24,964    25,564    28,757    29,430
       Total Earnings. . . . . . . . . . . . .  $42,596    $50,501    $55,426   $48,254   $61,108   $54,970

Ratio of Earnings to Fixed Charges . . . . . .     1.95       2.30       2.22      1.88      2.12      1.86
</TABLE>
Case 1:06-cv-15011-AKH Document 3 Filed 12/08/2006 Page 1 of 1
**Exhibit
      32**





CERTIFICATION
      PURSUANT TO


18
      U.S.C.
      SECTION 1350,


AS
      ADOPTED PURSUANT TO


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002





In
      connection with the Annual Report of China Display Technologies, Inc. (the
      “Company”) on Form 10-Q for the three months ended June 30, 2008 as filed with
      the Securities and Exchange Commission on the date hereof(the “Report”), I,
      Lawrence Kwok-Yan Chan, Chief Executive Officer, and I, Jason Yip, Chief
      Financial Officer of the Company, hereby certify that




1)
            The
                Report fully complies with the requirements of Section 13(a) or 15(d)
                of
                the Securities Exchange Act of 1934, as amended;
                and





2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and results of operations of the
                Company.




Dated:
                Aug 12, 2008
            /s/
                Lawrence Kwok-Yan ChanName:Title:
                Chief Executive OfficerDated:
                Aug 12, 2008
            /s/
                Jason YeName:
                Jason YeTitle:
                Chief Financial Officer





A
      signed
      original of this written statement required by Section 906, or other document
      authenticating, acknowledging, or otherwise adopting the signature that appears
      in typed form within the electronic version of this written statement has been
      provided to the Company and will be retained by the Company and furnished to
      the
      Securities and Exchange Commission or its staff upon request.
#### WHITENER v. WHITENER

No. 260P82.

Case below: 56 N.C. App. 599.

Petition by plaintiff for discretionary review under G.S. 7A-31 denied 13 July 1982.
#### BOEHM v. BOARD OF PODIATRY EXAMINERS

No. 25 PC.

Case below: 41 N.C. App. 567.

Petition by plaintiff for writ of certiorari to North Carolina Court of Appeals denied 25 September 1979.
[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS
FOR THE ELEVENTH CIRCUIT

________________________ No. 20

- 11127 Non

- Argument Calendar

________________________ D.C. Docket No. 8:18

- cr - 00327

- SCB

- AEP

- 9

UNITED STATES OF AMERICA, Plaintiff

- Appellee,

versus HOMAR GUERRERO

- HERNANDEZ, Defendant

- Appellant.

________________________ Appeal from the United States District Court for the Middle District of Florida

________________________ ( December 8, 2020 ) Before MARTIN , BRANCH , and LUCK , Circuit Judges.
PER CURIAM:

USCA11 Case: 20-11127 Date Filed: 12/08/2020 Page: 1 of 22 Thomas A. Burns, appointed counsel for Homar Guerrero

- Hernandez in this direct criminal appeal, has moved to withdraw from further representation of the appellant and filed a brief pursuant to Anders v. California , 386 U.S. 738 (1967). Our independent review of the entir e record reveals that counsel’s assessment of the relative merit of the appeal is correct. Because independent examination of the entire record reveals no arguable issues of merit, counsel’s motion to withdraw is GRANTED , and Guerrero

- Hernandez’s convicti on s and sentence are AFFIRMED

.

USCA11 Case: 20-11127 Date Filed: 12/08/2020 Page: 2 of 2
[Federal Register Volume 70, Number 228 (Tuesday, November 29, 2005)]
[Notices]
[Pages 71608-71609]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-23448]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS

Office of Research and Development


Government Owned Invention Available for Licensing

AGENCY: Office of Research and Development, VA.

ACTION: Notice of Government Owned Invention Available for Licensing.

-----------------------------------------------------------------------

SUMMARY: The invention listed below is owned by the U.S. Government as 
represented by the Department of Veterans Affairs, and is available for 
licensing in accordance with 35 U.S.C. 207 and 37 CFR part 404 and/or 
Cooperative Research and Development Act (CRADA) Collaboration under 15 
U.S.C. 3710a to achieve expeditious commercialization of results of 
Federally-funded research and development. Foreign patents are filed on 
selected inventions to extend market coverage for U.S. companies and 
may also be available for licensing.

FOR FURTHER INFORMATION CONTACT: Technical and licensing information on 
the invention may be obtained by writing to: Amy E. Centanni, 
Department of Veterans Affairs, Director, Technology Transfer Program, 
Office of Research and Development, 810 Vermont Avenue, NW., 
Washington, DC 20420; fax: 202-254-0255; e-mail at: 
<a href="/cdn-cgi/l/email-protection#5e3f3327703d3b302a3f3030371e333f373270283f70393128"><span class="__cf_email__" data-cfemail="3455594d1a57515a40555a5a5d7459555d581a42551a535b42">[email protected]</span></a>.
    Any request for information should include the Number and Title for 
the relevant invention as indicated below. Issued patents may be 
obtained from the Commissioner of Patents, U.S. Patent and Trademark 
Office, Washington, DC 20231.

SUPPLEMENTARY INFORMATION: The invention available for licensing is: 
VHA No. 03-127 ``Cyclic Peptides of MUC1 and Methods of use Thereof.''


[[Page 71609]]


    Dated: November 22, 2005.
Gordon H. Mansfield,
Deputy Secretary of Veterans Affairs.
[FR Doc. 05-23448 Filed 11-28-05; 8:45 am]
BILLING CODE 8320-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the
Annual Report of Gentiva Health Services, Inc. (the Company) on Form 10-K for the period ended January 3, 2010 as filed with the Securities and Exchange Commission (the Report), I, John R. Potapchuk, Executive Vice
President, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of
the Company.

Date: March 16, 2010



/s/ John R. PotapchukJohn R. PotapchukExecutive Vice President,Chief Financial Officer and Treasurer
#### HUMANE SOCIETY OF BEAUFORT COUNTY v. TILLETT

No. 73PA82.

Case below: 55 N.C. App. 482.

Petition by defendant for discretionary review under G.S. 7A-31 denied 4 May 1982.
Exhibit 99.2




                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection  with the Quarterly  Report of Keystone  Consolidated  Industries,
Inc. (the Company) on Form 10-Q/A-1 for the period ended March 31, 2003 as filed
with the Securities and Exchange  Commission on the date hereof (the Report), I,
Bert E.  Downing,  Jr.,  Vice  President,  Chief  Financial  Officer,  Corporate
Controller, and Treasurer of the Company, certify, pursuant to 18 U.S.C.ss.1350,
as adopted pursuant toss.906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully  complies with the  requirements  of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects, the financial condition and result of operations of
          the Company.

A signed  original of this  written  statement  required by Section 906 has been
provided  to  Keystone  Consolidated  Industries,  Inc.  and will be retained by
Keystone  Consolidated  Industries,  Inc. and  furnished to the SEC or its staff
upon request.




/s/  Bert E. Downing, Jr.
-----------------------------------------
Bert E. Downing, Jr.
Vice President, Chief Financial Officer,
Corporate Controller and Treasurer
May 29, 2003
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 98-6979

UNITED STATES OF AMERICA, Plaintiff - Appellee, versus JASON DORIAN JONES, Defendant - Appellant.Appeal from the United States District Court for the Eastern District of North Carolina, at Raleigh. W. Earl Britt, Senior District Judge. (CR-95-94, CA-98-218-5-BR) Submitted: December 17, 1998 Decided: January 5, 1999 Before WILKINS, NIEMEYER, and TRAXLER, Circuit Judges. Dismissed by unpublished per curiam opinion. Jason Dorian Jones, Appellant Pro Se. Fenita Morris Shepard, OFFICE OF THE UNITED STATES ATTORNEY, Raleigh, North Carolina, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Jason Dorian Jones seeks to appeal the district court’s order denying his motion filed under 28 U.S.C.A. § 2255 (West 1994 & Supp. 1998). We have reviewed the record and the district court’sopinion and find no reversible error. Accordingly, we deny a certificate of appealability and dismiss the appeal on the reasoning of the district court. See United States v. Jones , Nos. CR-95-94; CA-98-218-5-BR (E.D.N.C. June 18, 1998). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
#### STATE v. JACKSON & MARSHALL

No. 324P82.

Case below: 57 N.C. App. 71.

Petition by defendant Jackson for discretionary review under G.S. 7A-31 denied 13 July 1982.
<PAGE>   1


THE LAMSON & SESSIONS CO. AND SUBSIDIARIES

EXHIBIT (11) - EARNINGS-PER-SHARE-CALCULATION


The following table sets forth the computation of basic and diluted earnings per
share:

(Dollars and shares in thousands)
<TABLE>
<CAPTION>
                                                                                 FIRST QUARTER ENDED
                                                                           -------------------------------
                                                                           1998                 1997
                                                                           -----------       --------------
<S>                                                                        <C>               <C>
  BASIC (LOSS) EARNINGS-PER-SHARE-COMPUTATION 
  ------------------------------------------- 
  Net (Loss) Income                                                        $     (326)       $       2,157
                                                                           ===========       ==============

  Average Common Shares Oustanding                                              13,416              13,306
                                                                           ===========       ==============

  Basic (Loss) Earnings Per Share                                          $     (0.02)               0.16
                                                                           ===========       ==============

  DILUTED (LOSS) EARNINGS PER SHARE COMPUTATION
  ---------------------------------------------
  Net (Loss) Income                                                        $      (326)      $        2,157
                                                                           ===========       ==============

  Basic Shares Oustanding                                                       13,416              13,306

  Stock Options Calculated Under the Treasury Stock Method                           -                 240
                                                                           -----------       --------------

  Total Shares                                                                  13,416              13,546

  Diluted (Loss) Earnings Per Share                                        $     (0.02)      $        0.16
                                                                           ===========       ==============
</TABLE>

                                      -10-
#### BONDSHU v. BONDSHU

No. 66 PC.

Case below: 28 N.C. App. 411.

Petition for discretionary review under G.S. 7A-31 denied 2 March 1976.
Case 7:07-cv-03432-CS-MDF     Document 41      Filed 06/18/2008     Page 1 of 1